We have been engaged by our biopharmaceutical client to expand their existing MSL team for another launch set for 2020. This is yet another Rare Disease asset.
They currently have 3 marketed products and a very robust pipeline from Preclinical to Phase III.
This launch will be their 4th product to hit the market making a difference in the lives of patients.
The total MSL team will be 10 which allows you the uniqueness of working across therapeutic areas and having a diverse disease portfolio within the Rare Disease space.
The Territories are listed below (click on territory to learn more):
The goal for this expansion is to have NYC on-boarded by March 1, 2019 and the build out completed by the first half of Q2.
If you or a colleague have a minimum of 3 years MSL experience in Rare/Orphan Disease or Nephrology, contact Donna Gross, RN at 267-483-5233 ext 101.
Donna Gross, Director Life Sciences Recruiting
Phone: 267-483-5233 ext. 101
The Bandish Group, LLC
Life Sciences Executive Search
1432 Easton Road, Suite 2B
Warrington, PA 18976